- Previous Close
700.75 - Open
711.20 - Bid 664.60 x --
- Ask --
- Day's Range
661.60 - 711.20 - 52 Week Range
365.15 - 740.10 - Volume
65,140 - Avg. Volume
50,621 - Market Cap (intraday)
501.745B - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
76.48 - EPS (TTM)
8.69 - Earnings Date Feb 5, 2025 - Feb 10, 2025
- Forward Dividend & Yield 1.00 (0.14%)
- Ex-Dividend Date Jul 24, 2024
- 1y Target Est
677.00
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was founded in 1995 and is based in Gurugram, India.
www.fortishealthcare.com12,088
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: FORTIS.BO
View MorePerformance Overview: FORTIS.BO
Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FORTIS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FORTIS.BO
View MoreValuation Measures
Market Cap
529.04B
Enterprise Value
534.58B
Trailing P/E
80.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.29
Price/Book (mrq)
6.74
Enterprise Value/Revenue
7.37
Enterprise Value/EBITDA
37.45
Financial Highlights
Profitability and Income Statement
Profit Margin
8.97%
Return on Assets (ttm)
5.06%
Return on Equity (ttm)
8.19%
Revenue (ttm)
73.13B
Net Income Avi to Common (ttm)
6.56B
Diluted EPS (ttm)
8.69
Balance Sheet and Cash Flow
Total Cash (mrq)
6.01B
Total Debt/Equity (mrq)
13.59%
Levered Free Cash Flow (ttm)
4.76B